Molecular Medicine

, Volume 18, Issue 2, pp 209–214 | Cite as

Resveratrol Improves Cardiac Contractility following Trauma-Hemorrhage by Modulating Sirt1

  • Bixi Jian
  • Shaolong Yang
  • Irshad H. Chaudry
  • Raghavan Raju
Research Article


Mitochondria play a critical role in metabolic homeostasis of a cell. Our recent studies, based on the reported interrelationship between c-Myc and Sirt1 (mammalian orthologue of yeast sir2 [silent information regulator 2]) expression and their role in mitochondrial biogenesis and function, demonstrated a significant downregulation of Sirt1 protein expression and an upregulation of c-Myc following trauma-hemorrhage (T-H). Activators of Sirt1 are known to improve mitochondrial function and the naturally occurring polyphenol resveratrol (RSV) has been shown to significantly increase Sirt1 activity by increasing its affinity to both NAD+ and the acetylated substrate. In this study we tested the salutary effect of RSV following T-H and its influence on Sirt1 expression. Rats were subjected to T-H or sham operation. RSV (8 mg/kg body weight, intravenously) or vehicle was administered 10 min after the onset of resuscitation, and the rats were killed 2 h following resuscitation. Sirtinol, a Sirt1 inhibitor, was administered 5 min prior to RSV administration. Cardiac contractility (±dP/dt) was measured and heart tissue was tested for Sirt1, Pgc-1α, c-Myc, cytosolic cytochrome C expression and ATP level. Left ventricular function, after T-H, was improved (P < 0.05) following RSV treatment, with significantly elevated expression of Sirt1 (P < 0.05) and Pgc-1α (P < 0.05), and decreased c-Myc (P < 0.05). We also observed significantly higher cardiac ATP content, declined cytosolic cytochrome C and decreased plasma tumor necrosis factor-α in the T-H-RSV group. The salutary effect due to RSV was abolished by sirtinol, indicating a Sirtl-mediated effect. We conclude that RSV may be a useful adjunct to resuscitation fluid following T-H.



The study was supported by NIH grants AG 031440 (R Raju), GM R01 39519 (IH Chaudry) and a University of Alabama HSF-GEF Scholar Award (R Raju).


  1. 1.
    Mizushima Y, et al. (2000). Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann. Surg. 232:673–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Yarlagadda S, et al. (2006). Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocrit. Care. 5:102–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Sayeed MM, Zhu M, Maitra SR. (1989). Alterations in cellular calcium and magnesium during circulatory/septic shock. Magnesium. 8:179–89.PubMedGoogle Scholar
  4. 4.
    Ayala A, Ertel W, Chaudry IH. (1996). Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock. 5:79–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Ba ZF, et al. (2000). Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit. Care Med. 28:2837–42.CrossRefPubMedGoogle Scholar
  6. 6.
    Bulger EM, Cuschieri J, Warner K, Maier RV. (2007). Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Ann. Surg. 245:635–41.CrossRefPubMedGoogle Scholar
  7. 7.
    Dewar D, Moore FA, Moore EE, Balogh Z. (2009). Postinjury multiple organ failure. Injury. 40:912–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Raju R, Bland KI, Chaudry IH. (2008). Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations. Mol. Med. 14:213–21.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Rushing GD, Britt LD. (2008). Reperfusion injury after hemorrhage: a collective review. Ann. Surg. 247:929–37.CrossRefPubMedGoogle Scholar
  10. 10.
    Spinella PC, Holcomb JB. (2009). Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev. 23:231–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Ambrosio G, Flaherty JT. (1992). Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts. Cardiovasc. Drugs Ther. 6:623–32.CrossRefPubMedGoogle Scholar
  12. 12.
    Chen Q, Lesnefsky EJ. (2006). Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic. Biol. Med. 40:976–82.CrossRefPubMedGoogle Scholar
  13. 13.
    Childs EW, et al. (2002). In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. Shock. 18:423–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Hsieh YC, et al. (2006) Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1. Am. J. Physiol. Heart Circ. Physiol. 290:H416–23.CrossRefPubMedGoogle Scholar
  15. 15.
    Jian B, Yang S, Chen Q, Chaudry I, Raju R. (2011) Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial function. Biochim. Biophys. Acta. 1812:1445–51.Google Scholar
  16. 16.
    Petrovski G, Gurusamy N, Das DK. (2011). Resveratrol in cardiovascular health and disease. Ann. N. Y. Acad. Sci. 1215:22–33.CrossRefPubMedGoogle Scholar
  17. 17.
    Renaud S, de LM. (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1523–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Koo SH, Montminy M. (2006). In vino veritas: a tale of two sirt1s? Cell. 127:1091–3.CrossRefPubMedGoogle Scholar
  19. 19.
    Park SK, et al. (2009). Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants. Aging Cell. 8:484–95.CrossRefPubMedGoogle Scholar
  20. 20.
    Csiszar A, et al. (2006). Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am. J. Physiol. Heart Circ. Physiol. 291:H1694–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Das S, et al. (2005). Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul. Pharmacol. 42:281–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Lekli I, et al. (2008). Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. Am. J. Physiol. Heart Circ. Physiol. 294: H859–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Hao HD, He LR. (2004). Mechanisms of cardiovascular protection by resveratrol. J. Med. Food. 7:290–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Lagouge M, et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127:1109–22.CrossRefPubMedGoogle Scholar
  25. 25.
    la-Morte D, et al. (2009). Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience. 159:993–1002.CrossRefGoogle Scholar
  26. 26.
    Lopez-Lluch G, Irusta PM, Navas P, de CR. (2008). Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 43:813–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Pervaiz S, Holme AL. (2009). Resveratrol: its biologic targets and functional activity. Antioxid. Redox. Signal. 11:2851–97.CrossRefPubMedGoogle Scholar
  28. 28.
    Vingtdeux V, et al. (2010). AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 285:9100–13.CrossRefPubMedGoogle Scholar
  29. 29.
    Jian B, et al. (2011). Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury. Mol. Med. 17(5–6):542–9.PubMedGoogle Scholar
  30. 30.
    Jian B, et al. (2008). Activation of endoplasmic reticulum stress response following traumahemorrhage. Biochim. Biophys. Acta. 1782:621–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Yuan J, Minter-Dykhouse K, Lou Z. (2009). A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. J. Cell Biol. 185:203–11.CrossRefPubMedGoogle Scholar
  32. 32.
    Ghanim H, et al. (2011). A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab. 96:1409–14.CrossRefPubMedGoogle Scholar
  33. 33.
    Alcain FJ, Villalba JM. (2009). Sirtuin activators. Expert Opin. Ther. Pat. 19:403–14.CrossRefPubMedGoogle Scholar
  34. 34.
    Zingarelli B, et al. (2009). Lung injury after hemorrhage is age dependent: role of peroxisome proliferator-activated receptor gamma. Crit. Care Med. 37:1978–87.CrossRefPubMedGoogle Scholar
  35. 35.
    Hsieh YC, et al. (2006). Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J. Mol. Cell. Cardiol. 41:511–21.CrossRefPubMedGoogle Scholar
  36. 36.
    Wang P, et al. (2010). Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart. Circ. Res. 106:911–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Zou L, et al. (2009). Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-kappaB signaling. Am. J. Physiol. Heart Circ. Physiol. 296:H515–23.CrossRefPubMedGoogle Scholar
  38. 38.
    Raju R, Jian B, Hubbard W, Chaudry I. (2011). The mitoscriptome in aging and disease. Aging Dis. 2:174–80.PubMedCentralPubMedGoogle Scholar
  39. 39.
    Kan WH, et al. (2008). Flutamide protects against trauma-hemorrhage-induced liver injury via attenuation of the inflammatory response, oxidative stress, and apopotosis. J. Appl. Physiol. 105:595–602.CrossRefPubMedGoogle Scholar
  40. 40.
    Yang R, et al. (2006). Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 12:105–14.CrossRefPubMedGoogle Scholar
  41. 41.
    Meldrum DR, et al. (1997). Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J. Mol. Cell. Cardiol. 29:2849–54.CrossRefPubMedGoogle Scholar
  42. 42.
    Singh UP, et al. (2010). Resveratrol (trans-3,5,4′-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 332:829–39.CrossRefPubMedGoogle Scholar
  43. 43.
    Yu HP, Yang SC, Lau YT, Hwang TL. (2010). Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage. Surgery. 148:103–9CrossRefPubMedGoogle Scholar
  44. 44.
    Picard F, et al. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 429:771–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Pruitt K, et al. (2006). Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2:e40.CrossRefPubMedGoogle Scholar
  46. 46.
    Finkel T, Deng CX, Mostoslavsky R. (2009). Recent progress in the biology and physiology of sirtuins. Nature. 460:587–91.CrossRefPubMedGoogle Scholar
  47. 47.
    Wang C, et al. (2006). Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell. Biol. 8:1025–31.CrossRefPubMedGoogle Scholar
  48. 48.
    Lindstrom MS, Wiman KG. (2003). Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Oncogene. 22:4993–5005.CrossRefPubMedGoogle Scholar
  49. 49.
    Anekonda TS, Reddy PH. (2006). Neuronal protection by sirtuins in Alzheimer’s disease. J. Neurochem. 96:305–13.CrossRefPubMedGoogle Scholar
  50. 50.
    Voelter-Mahlknecht S, Mahlknecht U. (2006). Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int. J. Mol. Med. 17:59–67.PubMedGoogle Scholar
  51. 51.
    Ahuja P, et al. (2010). Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J. Clin. Invest. 120:1494–505.CrossRefPubMedGoogle Scholar
  52. 52.
    Wang C, Tai Y, Lisanti MP, Liao DJ. (2011). c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. Cancer Biol. Ther. 11:615–26.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2012

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (

Authors and Affiliations

  • Bixi Jian
    • 1
  • Shaolong Yang
    • 1
  • Irshad H. Chaudry
    • 1
    • 2
    • 3
  • Raghavan Raju
    • 1
    • 2
    • 3
  1. 1.Center for Surgical Research, Department of Surgery, VH-G094, Volker HallUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of MicrobiologyUniversity of Alabama at BirminghamBirminghamUSA
  3. 3.Center for Cardiovascular BiologyUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations